Introducing fatty acid oxidation inhibitors mitigated the knock-down effects, confirming that uncontrolled up-regulation of fatty acid oxidation promotes BC cell death; thus, HCAR3 plays a vital role in controlling fatty acid metabolism in BC cells [5]. Here, HCAR3 is linked to breast cancer.